• 800 343 7475ir@bio-techne.com bio-techne.com

    • Overview
    • News / Events
    • Company Information
    • Strategy
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    Navigation

      News / Events

    • Overview
    • News / Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Profile
      • Presentations
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
      • Annual Reports
    • Stock Data
      • Overview
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • 10-K Filings
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents

    Press Releases

    • News / Events

    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    Mar 23, 2021

    Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test

    Mar 15, 2021

    Bio-Techne Announces ISO 9001:2015 Certification for its Bristol Manufacturing Facility.

    Mar 8, 2021

    Bio-Techne Announces ExoTRU Kidney Transplant Rejection Assay Data Publication

    Mar 3, 2021

    Bio-Techne to Acquire Asuragen

    Mar 2, 2021

    Bio-Techne To Present At The Barclays Global Healthcare Conference

    Mar 1, 2021

    Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana

    Feb 25, 2021

    Bio-Techne Announces ISO 14001:2015 Certification for the EMEA region of Bio-Techne.

    Feb 23, 2021

    Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster™ for the development of Luminary's CAR-T cell therapies

    Feb 16, 2021

    Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference

    Feb 11, 2021

    Bio-Techne Announces Paper Publication In Annals Of Oncology

    RSS
    • 1...
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • ...49
    • Email Alerts
    • Contacts
    • RSS News Feed
    Bio-Techne

    614 McKinley Place NE
    Minneapolis, MN 55413
    USA

    TEL 612 379 2956
    Toll-free 800 343 7475
    FAX 612 656 4400

    Who We Are

    • About Bio-Techne
    • Bio-Techne Brands
    • Careers
    • Corporate & Social Responsibility
    • Terms and Conditions

    Investor Relations

    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance

    Stay Connected

    • Facebook Twitter LinkedIn YouTube Instagram
    • Contact Us

    Utility Footer Menu

    • Privacy and Cookie Policy
    • Site Map
    • © Copyright 2025 Bio-Techne. All Rights Reserved.